Alcohol Abstinence Challenge for Excessive Alcohol Consumption
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a 30-day alcohol abstinence challenge, supported by a mobile health app, can help reduce high-risk drinking. Participants will avoid alcohol for 30 days and complete daily surveys about their drinking habits. Follow-up surveys will occur one and three months after the challenge. This trial suits adults who regularly consume alcohol and are interested in taking a break. Eligibility will be further assessed through a Zoom call with the research team. As an unphased trial, this study offers a unique opportunity to explore personal health benefits and contribute to a broader understanding of alcohol abstinence.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the research staff during the Zoom screening.
What prior data suggests that the 30-Day Alcohol Abstinence Challenge is safe?
Research has shown that the 30-Day Alcohol Abstinence Challenge is safe. Studies found that 72.3% of eligible heavy drinkers participated without experiencing serious health problems. No major negative health effects were reported. Participants found the challenge manageable and safe, indicating it is a well-tolerated approach.12345
Why are researchers excited about this trial?
Researchers are excited about the 30-Day Alcohol Abstinence Challenge because it offers a straightforward, behavioral approach to managing excessive alcohol consumption without relying on medication. Unlike traditional treatments such as medications or counseling, this challenge emphasizes personal commitment and self-monitoring through daily and follow-up surveys. This method not only empowers participants to take control of their alcohol use but also provides valuable data on drinking patterns and abstinence sustainability. Researchers hope to uncover insights into the effectiveness of a structured abstinence period in reducing long-term alcohol consumption.
What evidence suggests that the 30-Day Alcohol Abstinence Challenge is effective for reducing high-risk drinking?
Research has shown that a 30-day break from alcohol can be very effective. In one study, 66% of participants avoided alcohol for the entire 30 days. Another study found that 89% of those who completed the challenge remained alcohol-free. Many participants reported better sleep and fewer alcohol cravings. Overall, most people who try these challenges notice positive changes in their drinking habits. Participants in this trial will engage in a 30-day alcohol abstinence challenge, with daily surveys monitoring alcohol consumption and follow-up surveys assessing long-term effects.34567
Who Is on the Research Team?
Sophia You, PhD, ABPP
Principal Investigator
University of Oklahoma
Are You a Good Fit for This Trial?
This trial is for adults aged 18 and older who regularly drink alcohol. Participants will be further screened by a research staff member over Zoom to confirm eligibility.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Challenge Monitoring
Participants fill out daily surveys monitoring alcohol consumption
30-Day Reset Challenge
Participants take part in a 30-day alcohol abstinence challenge
Follow-up
Participants complete 1 and 3-month follow-up surveys after the challenge
What Are the Treatments Tested in This Trial?
Interventions
- 30-Day Alcohol Abstinence Challenge
Trial Overview
The study tests whether a 30-day mobile app-based challenge to stop drinking alcohol can help reduce high-risk drinking. All participants take part in the same program; there is no comparison group.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will take part in a 30-day alcohol abstinence challenge. For 2 weeks before, and during the challenge participants will fill out daily surveys monitoring alcohol consumption. Additionally, there will be a longer 1 and 3-month follow-up survey after the completion of the challenge.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
Presbyterian Health Foundation
Collaborator
Citations
Alcohol use disorder: Pharmacologic management
Several medications can be used to treat alcohol use disorder, leading to reduced heavy drinking and increased days of abstinence [3]. These ...
How Long To Reverse Effects of Alcohol Abuse?
Typically, any reversal of damage occurs rapidly in the first months to the first year of abstinence and then slows down following that.
3.
recoveryanswers.org
recoveryanswers.org/research-post/temporary-alcohol-abstinence-challenges-lead-to-lasting-reductions/Temporary alcohol abstinence challenges may lead to ...
Of those who completed the entire study, 89% abstained from alcohol during the monthly challenge. Alcohol consumption decreased from an average of 6.5 standard ...
Evaluating a 30-day alcohol abstinence challenge in heavy ...
Most challengers (94.1%) reported some benefit from the challenge, which included improvements in alcohol withdrawal symptoms, sleep, and alcohol abstinence ...
Evaluating a 30-day alcohol abstinence challenge in heavy ...
Dry January has shown a high success rate for abstaining alcohol 30 days (66%) [15–18]. More importantly, both successful and unsuccessful ...
Alcohol Use and Your Health
Excessive alcohol use is a term used to describe four ways that people drink alcohol that can negatively impact health. Excessive drinking can also be deadly.
Evaluating a 30-day alcohol abstinence challenge in heavy ...
Evaluating a 30-day alcohol abstinence challenge in heavy-drinking individuals with and without chronic pain: Feasibility, safety, and perceived benefits.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.